Agenus (AGEN) Stock Forecast, Price Target & Predictions
AGEN Stock Forecast
Agenus stock forecast is as follows: an average price target of $8.00 (represents a 179.72% upside from AGEN’s last price of $2.86) and a rating consensus of 'Hold', based on 4 wall street analysts offering a 1-year stock forecast.
AGEN Price Target
AGEN Analyst Ratings
Hold
Agenus Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Jul 19, 2024 | Biren Amin | Jefferies | $7.00 | $5.99 | 16.86% | 144.76% |
Jul 19, 2024 | Colleen Kusy | Robert W. Baird | $8.00 | $7.30 | 9.59% | 179.72% |
Jul 18, 2024 | Emily Bodnar | H.C. Wainwright | $9.00 | $7.98 | 12.85% | 214.69% |
Jul 01, 2024 | Emily Bodnar | H.C. Wainwright | $40.00 | $16.75 | 138.81% | 1298.60% |
10
Agenus Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | - | - | 4 |
Avg Price Target | - | - | $16.00 |
Last Closing Price | $2.86 | $2.86 | $2.86 |
Upside/Downside | -100.00% | -100.00% | 459.44% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Aug 14, 2024 | B. Riley | Buy | Buy | Hold |
Jul 19, 2024 | Jefferies | - | Hold | Downgrade |
Jul 18, 2024 | William Blair | - | Market Perform | Downgrade |
Jul 18, 2024 | H.C. Wainwright | Buy | Neutral | Downgrade |
Jul 01, 2024 | H.C. Wainwright | Buy | Buy | Hold |
10
Agenus Financial Forecast
Agenus Revenue Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - | - | - | - | - | - | - | $83.80M | $24.31M | $25.30M | $22.90M | $28.39M | $22.77M | $20.93M | $25.94M | $20.26M | $252.95M | $10.73M | $11.72M | $31.26M | $14.83M | $26.95M | $15.13M | $34.50M | $19.94M |
Avg Forecast | $96.42M | $92.53M | $86.73M | $80.91M | $52.53M | $64.61M | $64.21M | $26.31M | $36.46M | $33.48M | $63.48M | $47.17M | $47.05M | $24.33M | $24.13M | $22.98M | $17.83M | $20.69M | $18.70M | $11.80M | $37.74M | $183.10M | $20.41M | $14.53M | $16.23M | $14.00M | $9.33M | $12.35M | $13.03M | $15.60M |
High Forecast | $174.92M | $167.85M | $157.32M | $146.76M | $95.29M | $117.21M | $116.47M | $47.72M | $78.51M | $60.73M | $63.48M | $47.17M | $64.49M | $24.33M | $43.78M | $41.68M | $32.34M | $20.69M | $18.70M | $11.80M | $37.74M | $183.10M | $20.41M | $14.53M | $16.23M | $14.00M | $9.33M | $12.35M | $13.03M | $15.60M |
Low Forecast | $62.00M | $59.50M | $55.76M | $52.02M | $33.77M | $41.55M | $41.28M | $16.91M | $18.75M | $21.52M | $63.48M | $47.17M | $22.42M | $24.33M | $15.52M | $14.77M | $11.46M | $20.69M | $18.70M | $11.80M | $37.74M | $183.10M | $20.41M | $14.53M | $16.23M | $14.00M | $9.33M | $12.35M | $13.03M | $15.60M |
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 1 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 9 | 9 | 9 | 9 | 8 | 8 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.78% | 1.00% | 1.05% | 1.00% | 1.59% | 1.10% | 1.12% | 2.20% | 0.54% | 1.38% | 0.53% | 0.81% | 1.93% | 1.06% | 2.89% | 1.22% | 2.65% | 1.28% |
Forecast
Agenus EBITDA Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 1 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 9 | 9 | 9 | 9 | 8 | 8 |
EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | $-4.36M | $442.00K | $2.14M | $-52.15M | $-52.82M | $-39.41M | $-34.22M | $-34.28M | $-47.28M | $196.81M | $-64.89M | $-36.06M | $-19.57M | $-33.09M | $-31.06M | $-28.94M | $-16.54M | $-33.14M |
Avg Forecast | $-61.86M | $-59.36M | $-55.64M | $-51.90M | $-33.70M | $-41.45M | $-41.19M | $-16.88M | $-23.39M | $-21.47M | $-40.72M | $-37.59M | $-30.19M | $-15.61M | $-15.48M | $-40.21M | $-14.53M | $-13.06M | $-11.80M | $-43.00M | $-23.82M | $-115.56M | $-12.88M | $-40.71M | $-10.24M | $-8.84M | $-5.89M | $-30.69M | $-8.22M | $-9.85M |
High Forecast | $-39.77M | $-38.17M | $-35.77M | $-33.37M | $-21.67M | $-26.65M | $-26.48M | $-10.85M | $-12.03M | $-13.81M | $-40.72M | $-30.08M | $-14.38M | $-15.61M | $-9.95M | $-32.17M | $-11.62M | $-13.06M | $-11.80M | $-34.40M | $-23.82M | $-115.56M | $-12.88M | $-32.57M | $-10.24M | $-8.84M | $-5.89M | $-24.55M | $-8.22M | $-9.85M |
Low Forecast | $-112.21M | $-107.68M | $-100.92M | $-94.15M | $-61.13M | $-75.19M | $-74.72M | $-30.61M | $-50.37M | $-38.96M | $-40.72M | $-45.11M | $-41.37M | $-15.61M | $-28.08M | $-48.25M | $-17.43M | $-13.06M | $-11.80M | $-51.60M | $-23.82M | $-115.56M | $-12.88M | $-48.85M | $-10.24M | $-8.84M | $-5.89M | $-36.83M | $-8.22M | $-9.85M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.14% | -0.03% | -0.14% | 1.30% | 3.64% | 3.02% | 2.90% | 0.80% | 1.99% | -1.70% | 5.04% | 0.89% | 1.91% | 3.75% | 5.28% | 0.94% | 2.01% | 3.37% |
Forecast
Agenus Net Income Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 1 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 9 | 9 | 9 | 9 | 8 | 8 |
Net Income | - | - | - | - | - | - | - | - | - | - | - | - | $-48.58M | $-62.25M | $-69.07M | $-67.85M | $-97.40M | $-74.28M | $-51.10M | $-63.47M | $-84.18M | $178.55M | $-83.29M | $-53.68M | $-37.61M | $-51.15M | $-47.48M | $-44.67M | $-30.05M | $-45.47M |
Avg Forecast | $-41.36M | $-43.45M | $-47.36M | $-51.63M | $-57.97M | $-46.33M | $-39.11M | $-54.20M | $-56.10M | $-49.86M | $-22.99M | $-57.74M | $-23.00M | $-84.07M | $-84.05M | $-61.75M | $-15.03M | $-77.51M | $-95.07M | $-66.04M | $-65.10M | $188.77M | $-100.59M | $-60.60M | $-90.94M | $-107.47M | $-112.99M | $-47.38M | $-157.08M | $-157.08M |
High Forecast | $-22.16M | $-23.28M | $-25.38M | $-27.67M | $-31.06M | $-24.83M | $-20.96M | $-29.04M | $16.43M | $-26.72M | $-12.32M | $-46.19M | $7.67M | $-45.05M | $-45.04M | $-49.40M | $-12.02M | $-77.51M | $-95.07M | $-52.84M | $-65.10M | $188.77M | $-100.59M | $-48.48M | $-90.94M | $-107.47M | $-112.99M | $-37.91M | $-157.08M | $-157.08M |
Low Forecast | $-85.12M | $-89.44M | $-97.48M | $-106.26M | $-119.31M | $-95.36M | $-80.50M | $-111.55M | $-81.89M | $-102.62M | $-47.31M | $-69.28M | $-57.51M | $-173.04M | $-172.98M | $-74.10M | $-18.04M | $-77.51M | $-95.07M | $-79.25M | $-65.10M | $188.77M | $-100.59M | $-72.72M | $-90.94M | $-107.47M | $-112.99M | $-56.86M | $-157.08M | $-157.08M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 2.11% | 0.74% | 0.82% | 1.10% | 6.48% | 0.96% | 0.54% | 0.96% | 1.29% | 0.95% | 0.83% | 0.89% | 0.41% | 0.48% | 0.42% | 0.94% | 0.19% | 0.29% |
Forecast
Agenus SG&A Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 1 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 9 | 9 | 9 | 9 | 8 | 8 |
SG&A | - | - | - | - | - | - | - | - | - | - | - | - | $21.18M | $18.91M | $20.41M | $18.24M | $25.04M | $18.11M | $18.91M | $18.95M | $21.97M | $21.39M | $16.65M | $16.35M | $20.03M | $14.38M | $14.20M | $10.61M | $12.32M | $11.51M |
Avg Forecast | $49.50M | $47.50M | $44.52M | $41.53M | $26.97M | $33.17M | $32.96M | $13.51M | $18.72M | $17.19M | $32.59M | $22.64M | $24.16M | $12.49M | $12.39M | $11.79M | $2.92M | $10.26M | $9.27M | $5.85M | $18.72M | $90.82M | $10.12M | $7.21M | $8.05M | $6.94M | $4.63M | $11.26M | $6.46M | $7.74M |
High Forecast | $89.80M | $86.17M | $80.77M | $75.34M | $48.92M | $60.17M | $59.79M | $24.50M | $40.31M | $31.18M | $32.59M | $27.17M | $33.11M | $12.49M | $22.47M | $21.40M | $3.50M | $10.26M | $9.27M | $5.85M | $18.72M | $90.82M | $10.12M | $7.21M | $8.05M | $6.94M | $4.63M | $13.51M | $6.46M | $7.74M |
Low Forecast | $31.83M | $30.54M | $28.63M | $26.71M | $17.34M | $21.33M | $21.19M | $8.68M | $9.63M | $11.05M | $32.59M | $18.12M | $11.51M | $12.49M | $7.97M | $7.58M | $2.33M | $10.26M | $9.27M | $5.85M | $18.72M | $90.82M | $10.12M | $7.21M | $8.05M | $6.94M | $4.63M | $9.00M | $6.46M | $7.74M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.88% | 1.51% | 1.65% | 1.55% | 8.59% | 1.76% | 2.04% | 3.24% | 1.17% | 0.24% | 1.64% | 2.27% | 2.49% | 2.07% | 3.07% | 0.94% | 1.91% | 1.49% |
Forecast
Agenus EPS Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 1 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 9 | 9 | 9 | 9 | 8 | 8 |
EPS | - | - | - | - | - | - | - | - | - | - | - | - | $-0.13 | $-0.16 | $-0.20 | $-0.21 | $-0.35 | $-0.26 | $-0.18 | $-0.25 | $-0.36 | $0.76 | $-0.37 | $-0.27 | $-0.19 | $-0.28 | $-0.28 | $-0.31 | $-0.21 | $-0.33 |
Avg Forecast | $-1.92 | $-2.02 | $-2.20 | $-2.40 | $-2.69 | $-2.15 | $-1.81 | $-2.52 | $-2.60 | $-2.31 | $-1.07 | $-3.21 | $-1.07 | $-3.90 | $-3.90 | $-4.14 | $-4.35 | $-3.68 | $-4.51 | $-5.84 | $-3.09 | $8.96 | $-4.78 | $-6.02 | $-4.32 | $-5.10 | $-5.36 | $-6.54 | $-7.46 | $-7.46 |
High Forecast | $-1.03 | $-1.08 | $-1.18 | $-1.28 | $-1.44 | $-1.15 | $-0.97 | $-1.35 | $0.76 | $-1.24 | $-0.57 | $-1.72 | $0.36 | $-2.09 | $-2.09 | $-2.22 | $-2.33 | $-3.68 | $-4.51 | $-5.84 | $-3.09 | $8.96 | $-4.78 | $-6.02 | $-4.32 | $-5.10 | $-5.36 | $-6.54 | $-7.46 | $-7.46 |
Low Forecast | $-3.95 | $-4.15 | $-4.52 | $-4.93 | $-5.54 | $-4.43 | $-3.74 | $-5.18 | $-3.80 | $-4.76 | $-2.20 | $-6.60 | $-2.67 | $-8.03 | $-8.03 | $-8.53 | $-8.95 | $-3.68 | $-4.51 | $-5.84 | $-3.09 | $8.96 | $-4.78 | $-6.02 | $-4.32 | $-5.10 | $-5.36 | $-6.54 | $-7.46 | $-7.46 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.12% | 0.04% | 0.05% | 0.05% | 0.08% | 0.07% | 0.04% | 0.04% | 0.12% | 0.08% | 0.08% | 0.04% | 0.04% | 0.05% | 0.05% | 0.05% | 0.03% | 0.04% |
Forecast
Agenus Peer Comparison by Price Target
Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
---|---|---|---|---|---|
XFOR | X4 Pharmaceuticals | $0.37 | $3.67 | 891.89% | Buy |
ADCT | ADC Therapeutics SA | $1.94 | $9.33 | 380.93% | Buy |
ADAP | Adaptimmune Therapeutics | $0.64 | $2.83 | 342.19% | Buy |
PDSB | PDS Bio | $2.20 | $9.00 | 309.09% | Buy |
AFMD | Affimed | $2.64 | $7.50 | 184.09% | Buy |
AGEN | Agenus | $2.86 | $8.00 | 179.72% | Hold |
LPTX | Leap Therapeutics | $2.58 | $5.50 | 113.18% | Buy |
VKTX | Viking Therapeutics | $51.63 | $102.40 | 98.33% | Buy |
MREO | Mereo BioPharma Group | $3.68 | $6.75 | 83.42% | Buy |
EWTX | Edgewise Therapeutics | $31.98 | $45.00 | 40.71% | Buy |
MDGL | Madrigal Pharmaceuticals | $329.24 | $315.75 | -4.10% | Buy |
TGTX | TG Therapeutics | $34.55 | $27.60 | -20.12% | Buy |